SEC Form 4 · accession 0001192482-15-000386
Recro Pharma, Inc. · REPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen Flynn
Director
Period of report
Sep 3, 2015
Accepted (ET)
Sep 8, 2015 · 8:42 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $13.89 | Sep 3, 2015 | A | 20,000 | A | — | Sep 3, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The option vests in three equal installments on September 3, 2016, 2017, and 2018.